Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hcw Biologics Inc (NQ: HCWB )

1.660 +0.070 (+4.40%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,566
Open 1.500
Bid (Size) 1.500 (2)
Ask (Size) 1.580 (1)
Prev. Close 1.590
Today's Range 1.500 - 1.670
52wk Range 0.9100 - 2.320
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
HCWB Stock Earnings: HCW Biologics Misses EPS, Misses Revenue for Q4 2023
HCWB stock results show that HCW Biologics missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace

Performance

YTD
+38.33%
+38.33%
1 Month
-6.21%
-6.21%
3 Month
+43.10%
+43.10%
6 Month
-9.15%
-9.15%
1 Year
+11.41%
+11.41%

More News

Read More
Why Anavex Life Sciences Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Looking Into HCW Biologics's Return On Capital Employed
Via Benzinga
Investigator Sponsor of HCW Biologics’ Phase 1 Clinical Trial Presented Human Data Readout and Anti-Cancer Mechanism of Action of HCW9218 at 38th SITC Annual Meeting
From HCW Biologics, Inc
Via GlobeNewswire
Masonic Cancer Center, University of Minnesota to Present Data in Poster Presentation Human Data Readout for Phase 1 Study to Evaluate HCW9218 in Solid Tumors at SITC 38th Annual Meeting
From HCW Biologics, Inc
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
HCW Biologics Participating at H.C. Wainwright 25th Annual Global Investment Conference in New York on September 11 – 13, 2023
From HCW Biologics, Inc
Via GlobeNewswire
Nerdy And 3 Other Stocks Under $4 Insiders Are Aggressively Buying
Via Benzinga
$3M Bet On This Technology Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
Via Benzinga
$25M Bet On This Consumer Cyclical Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
Via Benzinga
Recap: HCW Biologics Q1 Earnings
Via Benzinga
HCW Biologics: Q1 Earnings Insights
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
HCW Biologics Secures $26.25 Million Non-Dilutive Financing With Asset-Backed Development Loan
From HCW Biologics, Inc
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why SeaChange International Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
HCW Biologics Enters CRADA with National Cancer Institute
From HCW Biologics, Inc
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Smith Micro Software And 3 Other Stocks Under $3 Insiders Are Aggressively Buying
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2022
Via Benzinga
CASI Pharmaceuticals And 2 Other Stocks Under $4 Insiders Are Aggressively Buying
Via Benzinga
Why Minerva Neurosciences Shares Traded Higher By Over 66%; Here Are 78 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.